Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options-Reference-Cited by-同舟云学术

Substantial decline in heavily treated therapy-experienced persons with HIV with limited antiretroviral treatment options

Published:2020-10-13 Issue:14 Volume:34 Page:2051-2059
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Bajema Kristina L.,Nance Robin M.,Delaney Joseph A.C.,Eaton Ellen,Davy-Mendez Thibaut,Karris Maile Y.,Moore Richard D.,Eron Joseph J.,Rodriguez Benigno,Mayer Kenneth H.,Geng Elvin,Garris Cindy,Saag Michael S.,Crane Heidi M.,Kitahata Mari M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference48 articles.

1. Effect of early versus deferred antiretroviral therapy for HIV on survival;Kitahata;N Engl J Med,2009

2. Initiation of antiretroviral therapy in early asymptomatic HIV infection;Lundgren;N Engl J Med,2015

3. Antiretroviral therapy for the prevention of HIV-1 transmission;Cohen;N Engl J Med,2016

4. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART;Hogg;PLoS Med,2006

5. Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing;Lucas;AIDS,2004

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. US cost-utility model of lenacapavir plus optimized background regimen (OBR) vs fostemsavir plus OBR and ibalizumab plus OBR for people with HIV with multidrug resistance;Journal of Managed Care & Specialty Pharmacy;2024-09

2. Development of an extended action fostemsavir lipid nanoparticle;Communications Biology;2024-07-30

3. Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004–2021;The Journal of Infectious Diseases;2024-07-23

4. Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry;Journal of Antimicrobial Chemotherapy;2024-07-15

5. Heavily treatment-experienced persons living with HIV currently in care in Italy: characteristics, risk factors, and therapeutic options—the ICONA Foundation cohort study;International Journal of Infectious Diseases;2024-06